Do you have the same question? Follow this Question
Sep 18, 2024 - 12:38 PM
We’ve provided several answers to questions related to Combigan (Brimonidine / Timolol) , see some other helpful Q&A related to this product.
Question: What is the DrugBank ID for Brimonidine?
Answer: The DrugBank ID for Brimonidine is DB00484. DrugBank IDs provide detailed drug information beneficial for healthcare professionals.
Question: What are some conditions that require consultation before using Combigan?
Answer: Conditions such as asthma, COPD, serious heart problems, coronary artery disease, stroke, blood clot, high or low blood pressure, depression, diabetes, allergies, thyroid disorder, and history of glaucoma require consultation. This ensures patient safety and minimizes potential side effects.
Question: What is the protein binding percentage for Timolol?
Answer: Timolol has a protein binding percentage of 60%. Higher protein binding can influence the drug's efficacy and interaction with other medications.
Question: What is the bioavailability of Brimonidine when applied topically in the eye?
Answer: The bioavailability of Brimonidine when applied topically in the eye is not systemically quantified. This means its effectiveness is primarily localized to the eye, reducing potential systemic side effects.
Question: How should Combigan be administered?
Answer: Combigan should be administered as 1 drop in the eye pouch every 12 hours or as directed by a physician. Proper administration ensures the medication is effective in lowering eye pressure.
View all Combigan (Brimonidine / Timolol) Questions & Answers
